[Watchlist](7/5 - 7/11/20) <$MARK $CYDY $GNUS $WKHS $CHMA $SXTC $NBY $CIDM>
[Disclaimer]: I am not a professional, I expect you to do your own research and due diligence on any investment or trade that you may perform. None of the following is financial advice in any way shape or form. Trade at your own risk.
CytoDyn fights back against Citron, Remark estimations for earnings released, Cartoon Channel Battle Royale, EV plays and more!
<$CYDY CytoDyn Inc (OTC: CYDY) (Current Price: $6.0) (Float: 489.524M):>
CytoDyn Inc is US-based clinical-stage biotechnology company which focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The lead product candidate is PRO 140, which is a class of HIV therapy called as entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes on exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.
+ CytoDyn Releases Mechanism of Action Animation for Leronlimab in Immuno-Oncology
+ Short Seller Report: HIV Cure Challenger CytoDyn Takes on Gilead Sciences.
https://talkmarkets.com/content/hiv-cure-challenger-cytodyn-takes-on-the-gilead-sciences?post=267711
+ CytoDyn's CEO Dr. Pourhassan to Appear on DrBeen Webcast on July 4, 2020
+ CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution and Supply of Leronlimab for Treatment of COVID-19 in United States
I could expect this to fill the gap back to $10 where it cracked from the initial Citron reports. Even if it doesn't, definitely some positive price action with a short squeeze coming.
<CHART or SWING TRADE>
<$GNUS Genius Brands International Inc (NASDAQ: GNUS) (Current Price: $3.63) (Float: 92.066M):>
Genius Brands International Inc is a kids media company. It is engaged in developing, producing, marketing, and licensing branded children's entertainment properties and consumer products for media and retail distribution. Its portfolio features programming for toddlers to tweens, including the preschool properties Rainbow Rangers for Nick Jr. and Llama Llama for Netflix, toddler brand Baby Genius, STEM-based series Thomas Edison's Secret Lab, Warren Buffett's Secret Millionaires Club, and the new preschool show, Stan Lee's Superhero Kindergarten. The company's channel is available on television and mobile devices through distribution platforms, including Comcast, Cox, DISH, Sling TV, Apple TV, Roku, and Amazon Fire among others.
+ Genius Brands Chairman, CEO To Host Conference Call To Discuss Key Business Development; Call To Take Place 10 a.m. Monday, July 6
This ran hard Friday all day after the above announcement. Buy the rumor, sell the news, do not hold through this call, you have been warned. Don't expect a short squeeze unless it runs seriously high before 10am EST. Any smart shorts won't cover until after the call. $GNUS is heavily shorted right now, keep that in mind.
<CHART TRADE>
<$CIDM Cinedigm Corp (NASDAQ: CIDM) (Current Price: $2.34) (Float: 73.061M)
Cinedigm Corp is engaged in the media industry in the United States. It is a distributor and aggregator of the independent movie, television and other short-form content. It operates through two reportable segments as follows: Cinema Equipment Business and Content and Entertainment Business
+ FOX Entertainment's AVOD Service Tubi Adds 30 Seasons of Cult Phenom The Joy of Painting Featuring Bob Ross
+ Q4 Earnings due Monday July 6th before the opening bell. No estimations, keep in mind this is Q4 earnings if you are doing DD to figure out what type of financials to expect.
Expect a continued run up off the Bob Ross news to run up to earnings. Again I do not recommend holding through earnings unless you have done your DD and are damn sure of positive financials, with no estimations they will need to positive numbers here.
<CHART BEFORE EARNINGS or SWING TRADE BEYOND EARNINGS (IF GOOD, BUY THE DIP)>
<$WKHS Workhorse Group Inc (NASDAQ: WKHS) (Current Price: $20.19) (Float: 59.706M):>
Workhorse Group Inc is a technology company. It designs, develops, manufactures and sells high-performance, medium-duty trucks with powertrain components under the Workhorse chassis brand. The company's products include trucks comprising powertrain and chassis. Its powertrain products include E-GEN and E-100. E-GEN is an electric drive, transmission-free system, which has a gasoline/propane or compressed natural gas (CNG) engine that functions as an auxiliary generator. E-100, an all-electric, medium-duty truck, is an electric power train. The company generates key revenue from the Automotive Revenue which consists of sales of any of its E-GEN or E-100 platforms.
+ House-passed infrastructure bill gives USPS $25B for e-vehicles, facility updates. The bill specifies that $6 billion of that money would go toward buying a delivery vehicle fleet.
Many analysts feel the EV plays are way overbought right now and they may be right with most of them, however Workhorse's vehicles are built perfect for the USPS. That being said, while Trump appears to back this bill as well, I do not forsee the Senate passing it, no way in hell. It's still going to run really well and possibly other EV's off this news but you better not be holding it when the Senate announces their results. I could be wrong, but even if I am, buy the rumor sell the news, the EV plays are all priced in.
<CHART or SWING TRADE>
<$SXTC China SXT Pharmaceuticals Inc (NASDAQ: SXTC) (Current Price: $0.5315) (Float: 19.228M):>
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
+ Goldman Says “U.S. Tensions Won’t Hurt China Stocks Too Much, Yet”
+ Trump Tweet: New China Virus Cases up (because of massive testing), deaths are down, “low and steady”. The Fake News Media should report this and also, that new job numbers are setting records!
Not for nothing but PJ Matlock, Dan the Dip Deity, and crew are pumping this hard on twitter, expect results.
<CHART or SWING TRADE>
My Positions
<$MARK Remark Holdings Inc (NASDAQ: MARK) (Current Price: $2.38) (Float: 93.525M):> Remark Holdings Inc delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in a range of applications within the retail, financial, public safety, and workplace arenas. The company also owns and operates digital media properties that deliver relevant content and e-commerce solutions. The group operates in one segment namely Technology & Data Intelligence segment which provides products and services to customers based upon the data collected and processed by its proprietary data intelligence software.
+ Remark is in a really special place right now, they are set to be one of the possible companies to take full advantage of the world's economy needing to recover from COVID 19, forever changed, safety is a priority with thermal screening and immediate testing in high traffic and many businesses so that people feel safe to be there.
+ Remark also has highly anticipated Q1 earnings set to release on Monday July 6th after the close, estimated EPS -0.070 and estimated Revenue 1.31M
My expectations for $MARK are to beat those earnings, in both regards, I am holding a position, and whether I hold through earnings or sell before them largely depends on how high a runup to earnings there is. After earnings get ready to see some big action one way or the other.
<CHART or SWING TRADE to Q2>
<$NBY Novabay Pharmaceuticals (AMEX: NBY) (Current Price: $1.15) (Float: 18.294M):>
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.
+ Previous week Pence announced via news conference that masks should be mandatory, or strongly recommends wearing them to all Texans.
+ Last Friday Texas announced mandatory mask usage in counties with over 20 COVID 19 cases. Further DD showed this is still up to the counties to mandate.
Still expecting a runup this week, and into the future but I won't be holding this very long if at all beyond Monday.
<CHART or SWING TRADE>
<$CHMA Chiasma Inc (NASDAQ: CHMA) (Current Price: $4.6) (Float: 36.289M)
Chiasma Inc is a biopharmaceutical company that focuses on improving the lives of patients who face challenges associated with existing treatments for their rare and debilitating diseases. Its product candidate includes octreotide capsule which has completed Phase III clinical trial and it is being developed for the potential treatment of acromegaly, a rare, debilitating disease. The company offers its products in the United States and the European Union.
+ The current offering on $CHMA is expected to close Monday July 6th
Please view my previous watchlist and $CHMA blog post in regards to my further DD, this thing should run well after the closing of the offering.
<CHART or SWING TRADE>
Join now or log in to leave a comment